Vitamin K antagonists do not increase symptomatic intracranial hemorrhage in ischemic stroke patients
Written By : Jacinthlyn Sylvia
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-07-28 04:45 GMT | Update On 2023-07-28 09:22 GMT
Advertisement
A new study published in the Journal of American Medical Association shows that the use of vitamin K antagonist (VKA) within the previous seven days was not substantially linked to an elevated risk of symptomatic intracranial hemorrhage (sICH) overall among individuals with acute ischemic stroke who were chosen to receive endovascular thrombectomy (EVT).
The use of oral vitamin K antagonists (VKAs) may increase the risk of problems for patients having endovascular thrombectomy for acute ischemic stroke brought on by major artery blockage. In order to ascertain the relationship between recent usage of a VKA and results among patients chosen to undergo EVT in clinical practice, Brian Mac Grory and colleagues undertook this study.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.